What is MBX Biosciences, Inc.'s EPS (diluted)?

MBX Biosciences, Inc. (MBX) reported EPS (diluted) of -$0.50 in Q1 2026.

How has MBX Biosciences, Inc.'s EPS (diluted) changed year-over-year?

MBX Biosciences, Inc.'s EPS (diluted) increased by 29.6% year-over-year, from -$0.71 to -$0.50.

What does EPS (diluted) mean?

Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

MBX Biosciences, Inc. MBX EPS (Diluted)

EPS (Diluted) at other companies

Eli LillyLLY

$8.26+170%

AmgenAMGN

$3.34+4.4%

Viking TherapeuticsVKTX

-$1.37-234%

Amylyx Pharmaceuticals, Inc.AMLX

-$0.37+11.9%

BridgeBio PharmaBBIO

-$0.84+4.5%

Nurix Therapeutics, Inc.NRIX

-$0.79-17.9%

Other financials

Income statement

See full

Operating income-$27.3M-2.8%

Net income-$23.5M+1.5%

Balance sheet

See full

Cash & equivalents$45.2M+51.2%

Total debt$555.0K+327%

Total equity$437.8M+85.9%

Total assets$452.7M+84.1%

Cash flow

See full

Operating cash flow-$20.2M+10.9%

CapEx$437.0K+1,357%

Free cash flow-$20.6M+9.1%

Valuation

See full

Market cap$2.21B+475%

Enterprise value$2.16B+533%

Returns & leverage

See full

Return on equity-25.7%—

Debt / equity0×0.0×

Current ratio30.8×+7.5×

Where this comes from

Reported directly by MBX Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: MBX Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about MBX Biosciences, Inc.'s eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MBX Biosciences, Inc.'s EPS (diluted)?: MBX Biosciences, Inc. (MBX) reported EPS (diluted) of -$0.50 in Q1 2026.
How has MBX Biosciences, Inc.'s EPS (diluted) changed year-over-year?: MBX Biosciences, Inc.'s EPS (diluted) increased by 29.6% year-over-year, from -$0.71 to -$0.50.
What does EPS (diluted) mean?: Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.